✦ LIBER ✦

Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: An observational study with patients from the German Methotrexate Registry

✍ Scribed by A. Klein; I. Kaul; I. Foeldvari; G. Ganser; A. Urban; G. Horneff

Book ID: 115548536
Publisher: Wiley (John Wiley & Sons)
Year: 2012
Tongue: English
Weight: 128 KB
Volume: 64
Category: Article
ISSN: 2151-464X
DOI: 10.1002/acr.21697

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of a Combination The

Efficacy and Safety of a Combination Therapy of Methotrexate, Chloroquine and Cyclophosphamide in Patients with Refractory Rheumatoid Arthritis: Results of an Observational Study with Matched-Pair Analysis

✍ G. Keyszer; C. Keysser; M. Keysser 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 138 KB

An open-label pilot study of the efficac

An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX)

✍ Norma Jung; Matthias Hellmann; Reimund Hoheisel; Clara Lehmann; Ingo Haase; Andr 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 114 KB

MLN3897 plus methotrexate in patients wi

MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study

✍ Clarissa E. Vergunst; Danielle M. Gerlag; Lisa von Moltke; Michael Karol; Tim Wy 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 3 views

## Abstract ## Objective To assess the efficacy, safety, pharmacokinetics, and pharmacodynamics of the CC chemokine receptor CCR1 antagonist MLN3897 in patients with rheumatoid arthritis (RA) receiving methotrexate (MTX). ## Methods In this phase IIa, proof‐of‐concept study, patients meeting the

A phase II, randomized, double-blind, pl

A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis

✍ Michael Yellin; Igor Paliienko; Andra Balanescu; Semen Ter-Vartanian; Vira Tselu 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

Comparison of the clinical efficacy and

Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: Results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial

✍ J. Braun; P. Kästner; P. Flaxenberg; J. Währisch; P. Hanke; W. Demary; U. von Hi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB 👁 3 views

Long-term efficacy and safety of etanerc

Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: Interim results from an ongoing multicenter, open-label, extended-treatment trial

✍ Daniel J. Lovell; Edward H. Giannini; Andreas Reiff; Olcay Y. Jones; Rayfel Schn 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views